CN Patent

CN115594688B — 瑞卢戈利中间体的制备方法

Assigned to Chengdu Beite Pharmaceutical Co ltd · Expires 2023-11-17 · 3y expired

What this patent protects

本发明提供了一种瑞卢戈利中间体化合物I的制备方法，它是以化合物II为原料，在供氢体、钯碳和盐酸环境中还原反应生成化合物I。本发明提供的方法无需特种耐压、耐腐蚀设备，降低了生产设备成本投入。

USPTO Abstract

本发明提供了一种瑞卢戈利中间体化合物I的制备方法，它是以化合物II为原料，在供氢体、钯碳和盐酸环境中还原反应生成化合物I。本发明提供的方法无需特种耐压、耐腐蚀设备，降低了生产设备成本投入。

Drugs covered by this patent

Patent Metadata

Patent number
CN115594688B
Jurisdiction
CN
Classification
—
Expires
2023-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Beite Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.